Real-time FDG PET Guidance during Biopsies and Radiofrequency Ablation Using Multimodality Fusion with Electromagnetic Navigation

Aradhana M. Venkatesan, Samuel Kadoury, Nadine Abi‐Jaoudeh, Elliot Levy, Roberto Maass‐Moreno, Jochen Krücker, Sandeep Dalal, Sheng Xu, Neil Glossop, Bradford J. WoodRadiology 2011 · DOI

TL;DR

This paper introduces a novel system that fuses real-time ultrasound (US) and electromagnetic (EM) tracking with pre-acquired PET/CT scans to guide minimally invasive biopsies and radiofrequency (RF) ablations. This multimodality approach allows for precise targeting of metabolically active lesions that are difficult to visualize with conventional imaging alone, potentially improving diagnostic accuracy and treatment outcomes.

What Problem Does This Paper Address?

Fluorine-18 fluorodeoxyglucose (FDG) PET/CT is excellent for identifying metabolically active lesions, but its utility in guiding interventions like biopsies and ablations has been limited. Often, these FDG-avid lesions are not clearly delineated on standard anatomical imaging (CT or MRI), making it challenging to accurately target them for tissue sampling or treatment. This ambiguity can lead to missed diagnoses or ineffective treatments, especially for lesions with heterogeneous uptake or those that are completely invisible on conventional scans. The paper addresses this gap by developing a system that integrates real-time device tracking with fused PET/CT and US imaging to provide precise, dynamic guidance for these technically challenging procedures.

Methods

The core of the methodology involves a sophisticated integration of several technologies:

  • Electromagnetic (EM) Device Tracking: Miniature EM sensor coils embedded in biopsy needles and RF ablation electrodes are spatially tracked by an EM field generator. This allows for real-time determination of the device's position and orientation within the patient's anatomy.
  • Multimodality Image Fusion: Preprocedural FDG PET scans are rigidly registered to intraprocedural CT scans using a semiautomatic method. Real-time US scans are then registered to this fused PET/CT image using a fiducial-based method. This creates a comprehensive, dynamic visualization that overlays the metabolic information from PET onto the anatomical context of CT and real-time US.
  • Navigation Software: A custom software platform displays the fused PET/CT and US images with the overlaid trajectory of the tracked instruments. This software enables real-time feedback on the needle's position relative to the target lesion.
  • Fiducial Markers: Passive fiducial markers are placed on the skin to aid in the initial registration of the tracking system to the patient's anatomy.

The novelty lies in the seamless integration of these components to provide real-time, dynamic guidance, moving beyond static image fusion or retrospective analysis.

Datasets

The study utilized data from 25 patients (17 men, 8 women) who underwent 33 percutaneous and 3 intraoperative biopsies of 36 FDG-avid targets between November 2007 and August 2010. One patient also underwent RF ablation of an FDG-avid hepatic focus. The patients were selected based on the presence of FDG-avid lesions that were either poorly defined, inapparent on conventional imaging, or demonstrated heterogeneous uptake. No new benchmark datasets were introduced; rather, the study evaluated the system's performance on a cohort of patients with clinically challenging targets.

Key Insights and Ideas

  • Bridging the Gap: The system effectively bridges the gap between metabolic information from PET and the anatomical localization required for interventions, particularly for lesions invisible on conventional imaging.
  • Real-time Dynamic Guidance: Unlike previous methods that relied on static image fusion or retrospective analysis, this approach provides real-time feedback, allowing for immediate adjustments to needle trajectory based on fused PET/CT and US data.
  • Feasibility for Challenging Targets: The technology proved feasible for targeting lesions that would be technically difficult or impossible to biopsy or ablate using conventional image guidance alone.
  • Diagnostic Yield: The system contributed to diagnostic biopsies in a high proportion of cases, enabling the distinction between malignancy and benign processes.

Key Results

  • Successful Fusion: Real-time US scans were successfully fused with coregistered CT and FDG PET scans in all patients.
  • Diagnostic Biopsies: 31 out of 36 targeted biopsies were diagnostic (18 malignant, 13 benign).
  • RF Ablation Success: RF ablation resulted in the resolution of targeted FDG avidity with no local treatment failure during short follow-up (56 days).
  • Registration Accuracy: Mean PET/CT registration error was 1.14 mm, fiducial registration error was 1.73 mm, and mean basic tracking error was 5.85 mm.
  • Procedural Time: The mean procedural duration for tracked percutaneous biopsies and RF ablation was 1.62 hours, which was considered reasonable for complex procedures.

Limitations and Future Work

  • Short Follow-up: The study acknowledges a limitation of short clinical and imaging follow-up (mean 12.7 months).
  • Respiratory Motion: The inherent alignment uncertainties between PET and CT due to respiratory motion were not fully accounted for, although patients were coached to maintain shallow respirations.
  • Fiducial Registration Error: The uncertain effect of fiducial registration error on the true measure of error was noted.
  • Non-Randomized Trial: The study was not a randomized trial, and a prospective randomized multicenter trial comparing this technology with conventional guidance is planned.
  • Future Directions: The authors suggest that prospective randomized clinical studies are needed to define the specific clinical benefits of these technologies compared with conventional techniques in terms of time, radiation dose, and accuracy. They also highlight the potential for this technology to become more important with the increasing trend toward minimally invasive interventions.

Summary updated

Abstract

Combined electromagnetic device tracking and image fusion with real-time feedback may facilitate biopsies and ablations of focal FDG PET abnormalities that would be challenging with conventional image guidance.
BibTeX
@inproceedings{venkatesan2011real,
  author = {Aradhana M. Venkatesan and Samuel Kadoury and Nadine Abi‐Jaoudeh and Elliot Levy and Roberto Maass‐Moreno and Jochen Krücker and Sandeep Dalal and Sheng Xu and Neil Glossop and Bradford J. Wood},
  title = {{Real-time FDG PET Guidance during Biopsies and Radiofrequency Ablation Using Multimodality Fusion with Electromagnetic Navigation}},
  booktitle = {Radiology},
  year = {2011},
  doi = {10.1148/radiol.11101985},
}
Figure